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Anemia has been recognized as a very common and serious comorbidity in chronic heart failure (CHF) and chronic kidney disease (CKD), with a prevalence ranging from 10 to 79%, depending on diagnostic definition, disease severity and patient characteristics. A clear association of anemia with worse prognosis has been confirmed in multiple heart failure trials. This finding has recently triggered intense scrutiny in order to identify the underlying pathophysiologic mechanisms. Defective iron homeostasis is a major cause of anemia in patients with chronic heart failure, accompanied with chronic kidney disease but its origins are unknown. Aim: to understand the role of the inflammatory mediators: interleukin (IL-6) and hepcidin in iron deficiency in CHF and CKD.
Methods: 45 anemic CHF and CKD patients were examined (age 68±10years) - 55% male and 45% female. It was found that 60% of all anemic patients had III NYHA class and 40% of them - IV NYHA class. Control group included 15 non-anemic patients (age 66±11years) - 69% male and 31% female. Serum hepcidin and cytokine levels were measured by ELISA.
Results: Compared to controls and iron-replete CHF patients (transferring saturation (TSAT) ≥20%; n=16), iron-deficient CHF patients (TSAT< 20%; n=29) had lower haemoglobin (P<0.0001) and higher hepcidin (controls: 120±45 mg/mL; TSAT ≥20%: 132±74 mg/mL; TSAT < 20%: 192±122 mg/mL; P<0.05) and IL-6 (P<0.0001) levels. Negative correlation between hepcidin and haemoglobin (r = -  0.44, P<0.01) and positive correlation between hepcidin and IL-6 (r = 0.50, P<0.001) was found. Conclusion: Defective iron homeostasis in anemic CHF and CKD patients is associated with an immune-mediated up-regulation in hepcidin expression, central mediator that inhibits iron release and intestinal iron absorption. 

